Cargando…
Effect of modified Xiaochaihu decoction-containing serum on HepG2.2.15 cells via the JAK2/STAT3 signaling pathway
The present study aimed to investigate the possible mechanisms underlying the effect of modified Xiaochaihu decoction (mXCHD) in the treatment of chronic hepatitis B (CHB). Patients with CHB, in addition to liver stagnation and spleen deficiency syndrome were randomly assigned to receive either Chin...
Autores principales: | Chen, Shaofang, Wang, Zhanglin, Wan, Shichuan, Huang, Hai, Liang, Huiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865873/ https://www.ncbi.nlm.nih.gov/pubmed/28944901 http://dx.doi.org/10.3892/mmr.2017.7561 |
Ejemplares similares
-
TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway
por: Zhu, X, et al.
Publicado: (2016) -
IFN-CSP Inhibiting Hepatitis B Virus in HepG2.2.15 Cells Involves JAK-STAT Signal Pathway
por: Lu, Xuemei, et al.
Publicado: (2015) -
HBV Integration-mediated Cell Apoptosis in HepG2.2.15
por: Hu, Xiaoge, et al.
Publicado: (2019) -
Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling
por: Li, Lin, et al.
Publicado: (2016) -
Correction: Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling
por: Li, Lin, et al.
Publicado: (2016)